GA/HbA1c Ratio is a Simple and Practical Indicator to Evaluate the Risk of Metabolic Dysfunction-associated Fatty Liver Disease in Type 2 Diabetes: an Observational Study

Overview

Journal Diabetol Metab Syndr

Publisher Biomed Central

Specialty Endocrinology

Date 2022 Nov 11

PMID 36369095

Authors

Jun-Wei Wang

Chun-Hua Jin

Jiang-Feng Ke

Yi-Lin Ma

Yu-Jie Wang

Jun-Xi Lu

Mei-Fang Li

Lian-Xi Li

Affiliations

Soon will be listed here.

Abstract

Background: It is still debatable whether glycated albumin/glycated hemoglobin A1C (GA/HbA1C) ratio is associated with metabolic dysfunction-associated fatty liver disease (MAFLD), and few studies have been conducted in type 2 diabetes mellitus (T2DM). Therefore, we aimed to investigate the association between GA/HbA1C ratio and MAFLD and to evaluate whether GA/HbA1C ratio can be used an indicator of MAFLD in Chinese patients with T2DM.

Methods: This cross-sectional study consisted of 7117 T2DM patients including 3296 men and 3821 women from real-world settings. Abdominal ultrasonography was performed to diagnose MAFLD. In addition to comparing the clinical characteristics among the GA/HbA1C ratio quartile groups, we also investigated the associations of GA/HbA1C ratio and quartiles with MAFLD in T2DM subjects.

Results: There was a significantly decreased trend in the MAFLD prevalence across the GA/HbA1C ratio quartiles (56.3%, 47.4%, 37.8%, and 35.6% for the first, second, third, and fourth quartile, respectively, P < 0.001 for trend) after adjusting for gender, age, and diabetes duration. Fully adjusted Binary logistic regression indicated that both GA/HbA1C ratio (OR: 0.575, 95% CI: 0.471 to 0.702, P < 0.001) and quartiles (P < 0.001 for trend) were inversely associated with the presence of MAFLD among T2DM patients. Additionally, HOMA2-IR values were clearly increased in the T2DM subjects with MAFLD compared with those without MAFLD (P < 0.001), and markedly increased from the highest to the lowest GA/HbA1C ratio quartile (P < 0.001 for trend).

Conclusions: GA/HbA1C ratio is closely and negatively associated with MAFLD in T2DM subjects, which may attribute to that GA/HbA1C ratio reflects the degree of insulin resistance. GA/HbA1C ratio may act as a simple and practical indicator to evaluate the risk of MAFLD in T2DM.

Citing Articles

L-shaped association between the GA/HbA1c ratio and all-cause mortality in U.S. adults with NAFLD: a cross-sectional study from the NHANES 1999-2004.

Zhang Z, Wang H, Chen M, Chen Y BMC Endocr Disord. 2024; 24(1):35.

PMID: 38468235 PMC: 10926622. DOI: 10.1186/s12902-024-01568-7.

References

Li T, Wang A, Lu J, Chen M, Zhao C, Tang Z . Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes. Diabetes Metab. 2018; 44(5):437-443. DOI: 10.1016/j.diabet.2018.03.002. View

Bando Y, Kanehara H, Aoki K, Toya D, Notsumata K, Tanaka N . The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis. Ann Clin Biochem. 2012; 49(Pt 4):387-90. DOI: 10.1258/acb.2012.011139. View

Mukai N, Ohara T, Hata J, Hirakawa Y, Yoshida D, Kishimoto H . Alternative Measures of Hyperglycemia and Risk of Alzheimer's Disease in the Community: The Hisayama Study. J Clin Endocrinol Metab. 2017; 102(8):3002-3010. DOI: 10.1210/jc.2017-00439. View

Zhao C, Wang A, Li L, Li T, Chen M, Zhu Y . Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes. J Diabetes Complications. 2016; 30(6):1074-80. DOI: 10.1016/j.jdiacomp.2016.04.017. View

Bando Y, Kanehara H, Toya D, Tanaka N, Kasayama S, Koga M . Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease. Ann Clin Biochem. 2009; 46(Pt 5):368-72. DOI: 10.1258/acb.2009.008231. View

Jeon W, Park S, Rhee E, Lee W, Oh K, Park S . The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2016; 116:46-53. DOI: 10.1016/j.diabres.2016.04.018. View

He X, Mo Y, Ma X, Ying L, Zhu W, Wang Y . Associations of body mass index with glycated albumin and glycated albumin/glycated hemoglobin A ratio in Chinese diabetic and non-diabetic populations. Clin Chim Acta. 2018; 484:117-121. DOI: 10.1016/j.cca.2018.05.044. View

Browning J, Horton J . Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004; 114(2):147-52. PMC: 449757. DOI: 10.1172/JCI22422. View

Xu Y, Ma X, Shen Y, Wang Y, Zhou J, Bao Y . Increasing waist circumference is associated with decreased levels of glycated albumin. Clin Chim Acta. 2019; 495:118-122. DOI: 10.1016/j.cca.2019.04.001. View

10.

Koga M, Matsumoto S, Saito H, Kasayama S . Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients. Endocr J. 2006; 53(3):387-91. DOI: 10.1507/endocrj.k05-137. View

11.

Raghav A, Ahmad J, Noor S, Alam K, Mishra B . Glycated albumin and the risk of chronic kidney disease in subjects with Type 2 Diabetes: A study in North Indian Population. Diabetes Metab Syndr. 2018; 12(3):381-385. DOI: 10.1016/j.dsx.2018.01.005. View

12.

Lee S, Jang M, Kim Y, Park S, Kim C, Kim Y . Effect of Prestroke Glycemic Variability Estimated Glycated Albumin on Stroke Severity and Infarct Volume in Diabetic Patients Presenting With Acute Ischemic Stroke. Front Endocrinol (Lausanne). 2020; 11:230. PMC: 7186307. DOI: 10.3389/fendo.2020.00230. View

13.

Koga M, Inada S, Nakao T, Kawamori R, Kasayama S . The Glycated Albumin (GA) to HbA1c Ratio Reflects Shorter-Term Glycemic Control than GA: Analysis of Patients with Fulminant Type 1 Diabetes. J Clin Lab Anal. 2016; 31(1). PMC: 6816871. DOI: 10.1002/jcla.22023. View

14.

Liu F, Chen S, Zhao W, Chen M, Ke J, Zhang Z . Urine Uric Acid Excretion Levels are Positively Associated with Obesity and Abdominal Obesity in Type 2 Diabetes Patients without Chronic Kidney Disease. Diabetes Metab Syndr Obes. 2021; 14:4691-4703. PMC: 8646115. DOI: 10.2147/DMSO.S335558. View

15.

Ke J, Wang J, Lu J, Zhang Z, Liu Y, Li L . Waist-to-height ratio has a stronger association with cardiovascular risks than waist circumference, waist-hip ratio and body mass index in type 2 diabetes. Diabetes Res Clin Pract. 2021; 183:109151. DOI: 10.1016/j.diabres.2021.109151. View

16.

Jung C, Lee B, Choi D, Jung S, Kim B, Kim C . Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2017; 125:53-61. DOI: 10.1016/j.diabres.2016.12.017. View

17.

Zhang Z, Ke J, Lu J, Liu Y, Wang A, Li L . Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study. Diabetes Metab J. 2021; 46(1):129-139. PMC: 8831806. DOI: 10.4093/dmj.2020.0222. View

18.

Huh J, Kim K, Lee B, Kim D, Kang E, Cha B . The relationship between BMI and glycated albumin to glycated hemoglobin (GA/A1c) ratio according to glucose tolerance status. PLoS One. 2014; 9(2):e89478. PMC: 3938490. DOI: 10.1371/journal.pone.0089478. View

19.

Song S, Kim K, Lee B, Kang E, Cha B, Lee H . Serum glycated albumin predicts the progression of carotid arterial atherosclerosis. Atherosclerosis. 2012; 225(2):450-5. DOI: 10.1016/j.atherosclerosis.2012.09.005. View

20.

Ciardullo S, Grassi G, Mancia G, Perseghin G . Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2021; 34(4):365-371. PMC: 8876398. DOI: 10.1097/MEG.0000000000002299. View